# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011836
Filing Date
2021-05-17
Accepted
2021-05-17 16:06:28
Documents
87
Period of Report
2021-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 620813
2 |  | ex31.htm | EX-31 | 33840
3 |  | ex32.htm | EX-32 | 8531
| Complete submission text file | 0001493152-21-011836.txt |  | 5387189

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL INSTANCE FILE | ocx-20210331.xml | EX-101.INS | 890734
5 | XBRL SCHEMA FILE | ocx-20210331.xsd | EX-101.SCH | 76298
6 | XBRL CALCULATION FILE | ocx-20210331_cal.xml | EX-101.CAL | 100314
7 | XBRL DEFINITION FILE | ocx-20210331_def.xml | EX-101.DEF | 267686
8 | XBRL LABEL FILE | ocx-20210331_lab.xml | EX-101.LAB | 492591
9 | XBRL PRESENTATION FILE | ocx-20210331_pre.xml | EX-101.PRE | 395808

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 21930448
SIC: 2835 In Vitro & In Vivo Diagnostic Substances